MISP and hepatocellular carcinoma: While we detect the expression of MISP, CHMP2B, IL-18, TMSB4X, and EFEMP1 proteins in liver tissue samples from HCC patients receiving lenvatinib treatment, the same proteins were not detected in those receiving sorafenib treatment.